vs
アクサルタ（AXTA）とTENET HEALTHCARE CORP（THC）の財務データ比較。上の社名をクリックして会社を切り替えられます
TENET HEALTHCARE CORPの直近四半期売上が大きい（$5.5B vs $1.3B、アクサルタの約4.4倍）。TENET HEALTHCARE CORPの純利益率が高く（11.7% vs 4.8%、差は6.9%）。TENET HEALTHCARE CORPの前年同期比売上増加率が高い（9.0% vs -3.7%）。TENET HEALTHCARE CORPの直近四半期フリーキャッシュフローが多い（$367.0M vs $286.0M）。過去8四半期でTENET HEALTHCARE CORPの売上複合成長率が高い（1.5% vs -1.2%）
アクサルタは米国発祥の塗料専門企業で、本社はペンシルベニア州フィラデルフィア、登記所在地はバミューダである。乗用車・商用車向け、工業用、補修用の各種塗料の開発・製造を手がけ、130か国以上で事業を展開し、約1万3千人の従業員を擁している。
テネット・ヘルスケア・コーポレーションは米国ダラスに本社を置く営利目的の多国籍医療サービス企業です。USPIをはじめとするブランド・子会社・合弁事業・提携先を通じ、65の病院と450以上の医療施設を運営するほか、Conifer Health Solutionsで医療システムなどの顧客向けに医療支援サービスを提供しています
AXTA vs THC — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $1.3B | $5.5B |
| 純利益 | $60.0M | $644.0M |
| 粗利率 | 33.4% | — |
| 営業利益率 | 12.8% | 15.4% |
| 純利益率 | 4.8% | 11.7% |
| 売上前年比 | -3.7% | 9.0% |
| 純利益前年比 | -56.2% | 12.6% |
| EPS（希薄化後） | $0.28 | $4.22 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $1.3B | $5.5B | ||
| Q3 25 | $1.3B | $5.3B | ||
| Q2 25 | $1.3B | $5.3B | ||
| Q1 25 | $1.3B | $5.2B | ||
| Q4 24 | $1.3B | $5.1B | ||
| Q3 24 | $1.3B | $5.1B | ||
| Q2 24 | $1.4B | $5.1B | ||
| Q1 24 | $1.3B | $5.4B |
| Q4 25 | $60.0M | $644.0M | ||
| Q3 25 | $110.0M | $579.0M | ||
| Q2 25 | $109.0M | $522.0M | ||
| Q1 25 | $99.0M | $622.0M | ||
| Q4 24 | $137.0M | $572.0M | ||
| Q3 24 | $101.0M | $681.0M | ||
| Q2 24 | $112.0M | $477.0M | ||
| Q1 24 | $41.0M | $2.3B |
| Q4 25 | 33.4% | — | ||
| Q3 25 | 34.9% | — | ||
| Q2 25 | 35.0% | — | ||
| Q1 25 | 34.3% | — | ||
| Q4 24 | 34.1% | — | ||
| Q3 24 | 35.0% | — | ||
| Q2 24 | 34.0% | — | ||
| Q1 24 | 33.2% | — |
| Q4 25 | 12.8% | 15.4% | ||
| Q3 25 | 15.8% | 16.8% | ||
| Q2 25 | 14.8% | 15.6% | ||
| Q1 25 | 13.9% | 18.1% | ||
| Q4 24 | 14.3% | 16.2% | ||
| Q3 24 | 14.6% | 21.3% | ||
| Q2 24 | 15.2% | 14.9% | ||
| Q1 24 | 9.4% | 61.2% |
| Q4 25 | 4.8% | 11.7% | ||
| Q3 25 | 8.5% | 10.9% | ||
| Q2 25 | 8.4% | 9.9% | ||
| Q1 25 | 7.8% | 11.9% | ||
| Q4 24 | 10.5% | 11.3% | ||
| Q3 24 | 7.7% | 13.3% | ||
| Q2 24 | 8.3% | 9.3% | ||
| Q1 24 | 3.2% | 43.5% |
| Q4 25 | $0.28 | $4.22 | ||
| Q3 25 | $0.51 | $3.86 | ||
| Q2 25 | $0.50 | $3.14 | ||
| Q1 25 | $0.45 | $4.27 | ||
| Q4 24 | $0.63 | $3.79 | ||
| Q3 24 | $0.46 | $4.89 | ||
| Q2 24 | $0.51 | $2.64 | ||
| Q1 24 | $0.18 | $21.38 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $657.0M | $2.9B |
| 総負債低いほど良い | $3.2B | $13.1B |
| 株主資本純資産 | $2.3B | $4.2B |
| 総資産 | $7.6B | $29.7B |
| 負債/資本比率低いほどレバレッジが低い | 1.36× | 3.10× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $657.0M | $2.9B | ||
| Q3 25 | $606.0M | $3.0B | ||
| Q2 25 | $625.0M | $2.6B | ||
| Q1 25 | $575.0M | $3.0B | ||
| Q4 24 | $593.0M | $3.0B | ||
| Q3 24 | $567.0M | $4.1B | ||
| Q2 24 | $840.0M | $2.9B | ||
| Q1 24 | $624.0M | $2.5B |
| Q4 25 | $3.2B | $13.1B | ||
| Q3 25 | $3.4B | $13.1B | ||
| Q2 25 | $3.4B | $13.1B | ||
| Q1 25 | $3.4B | $13.1B | ||
| Q4 24 | $3.4B | $13.1B | ||
| Q3 24 | $3.5B | $12.8B | ||
| Q2 24 | $3.6B | $12.8B | ||
| Q1 24 | $3.4B | $12.8B |
| Q4 25 | $2.3B | $4.2B | ||
| Q3 25 | $2.3B | $4.0B | ||
| Q2 25 | $2.3B | $3.7B | ||
| Q1 25 | $2.1B | $4.2B | ||
| Q4 24 | $1.9B | $4.2B | ||
| Q3 24 | $1.9B | $3.8B | ||
| Q2 24 | $1.8B | $3.5B | ||
| Q1 24 | $1.7B | $3.5B |
| Q4 25 | $7.6B | $29.7B | ||
| Q3 25 | $7.8B | $29.4B | ||
| Q2 25 | $7.8B | $28.7B | ||
| Q1 25 | $7.4B | $29.2B | ||
| Q4 24 | $7.2B | $28.9B | ||
| Q3 24 | $7.5B | $29.4B | ||
| Q2 24 | $7.3B | $29.3B | ||
| Q1 24 | $7.1B | $28.9B |
| Q4 25 | 1.36× | 3.10× | ||
| Q3 25 | 1.48× | 3.26× | ||
| Q2 25 | 1.50× | 3.49× | ||
| Q1 25 | 1.64× | 3.13× | ||
| Q4 24 | 1.78× | 3.14× | ||
| Q3 24 | 1.84× | 3.33× | ||
| Q2 24 | 2.02× | 3.67× | ||
| Q1 24 | 1.97× | 3.70× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $344.0M | $731.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $286.0M | $367.0M |
| FCFマージンFCF / 売上 | 22.7% | 6.6% |
| 設備投資強度設備投資 / 売上 | 4.6% | 6.6% |
| キャッシュ転換率営業CF / 純利益 | 5.73× | 1.14× |
| 直近12ヶ月FCF直近4四半期 | $453.0M | $2.5B |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $344.0M | $731.0M | ||
| Q3 25 | $137.0M | $1.1B | ||
| Q2 25 | $142.0M | $936.0M | ||
| Q1 25 | $26.0M | $815.0M | ||
| Q4 24 | $234.0M | $-331.0M | ||
| Q3 24 | $194.0M | $1.0B | ||
| Q2 24 | $114.0M | $747.0M | ||
| Q1 24 | $34.0M | $586.0M |
| Q4 25 | $286.0M | $367.0M | ||
| Q3 25 | $87.0M | $778.0M | ||
| Q2 25 | $97.0M | $743.0M | ||
| Q1 25 | $-17.0M | $642.0M | ||
| Q4 24 | $172.0M | $-661.0M | ||
| Q3 24 | $161.0M | $829.0M | ||
| Q2 24 | $91.0M | $602.0M | ||
| Q1 24 | $12.0M | $346.0M |
| Q4 25 | 22.7% | 6.6% | ||
| Q3 25 | 6.8% | 14.7% | ||
| Q2 25 | 7.4% | 14.1% | ||
| Q1 25 | -1.3% | 12.3% | ||
| Q4 24 | 13.1% | -13.0% | ||
| Q3 24 | 12.2% | 16.2% | ||
| Q2 24 | 6.7% | 11.8% | ||
| Q1 24 | 0.9% | 6.4% |
| Q4 25 | 4.6% | 6.6% | ||
| Q3 25 | 3.9% | 5.3% | ||
| Q2 25 | 3.4% | 3.7% | ||
| Q1 25 | 3.4% | 3.3% | ||
| Q4 24 | 4.7% | 6.5% | ||
| Q3 24 | 2.5% | 4.2% | ||
| Q2 24 | 1.7% | 2.8% | ||
| Q1 24 | 1.7% | 4.5% |
| Q4 25 | 5.73× | 1.14× | ||
| Q3 25 | 1.25× | 1.83× | ||
| Q2 25 | 1.30× | 1.79× | ||
| Q1 25 | 0.26× | 1.31× | ||
| Q4 24 | 1.71× | -0.58× | ||
| Q3 24 | 1.92× | 1.53× | ||
| Q2 24 | 1.02× | 1.57× | ||
| Q1 24 | 0.83× | 0.25× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
AXTA
| Refinish | $509.0M | 40% |
| Light Vehicle | $372.0M | 29% |
| Industrial | $282.0M | 22% |
| Commercial Vehicle | $99.0M | 8% |
THC
| Other | $2.9B | 52% |
| Health Care Patient Service | $1.4B | 25% |
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $1.2B | 22% |
| Health Care Other Sources | $56.0M | 1% |
